A novel approach to removing excess fluid through the skin and a new strategy to prevent right ventricular failure after LVAD implantation are among the highlights of the January issue of the Journal ...
HIC built world-class cardiovascular care in Colombia by fusing together global standards, innovation and human-centered ...
Social determinants of health (SDOH) were found to be associated with increased risk of heart failure (HF) and ventricular arrhythmias (VA) in patients with hypertrophic cardiomyopathy (HCM), ...
Professional cardiology societies have issued an updated guideline for the management of adult patients with congenital heart ...
Stockhead on MSN
EBR shows a strong beat in Q4 as WiSE adoption accelerates
EBR Systems (ASX:EBR) gained FDA approval for WiSE in April 2025 and it is the world’s only wireless endocardial (placed ...
Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...
Trinity Health Ann Arbor has completed Michigan’s first implant of the world’s smallest device designed to help treat ...
Interventional cardiologists say some cases that coders flag and submit to the NCDR aren’t in fact problematic.
The Baptist Heart Institute has performed nearly 500 heart transplants since its founding. A recipient said the group was "full of miracle workers." ...
Ad feature presented by Shockwave Medical. The treatment giving people the potential to live an ordinary life after heart ...
MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...
John Montell “Monty” Mitchell was reeling last year. He heads into next year, though, freshly certified as a paramedic, committed to fatherhood and nurturing a dream that ends in the letters “M.D.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results